Alniche Life Sciences

What Alniche Life Sciences does

Alniche Life Sciences is a New Delhi-based specialty pharmaceutical company founded in 2007 that markets and distributes medicines across five therapy areas: Renal Care, Life Care, Skinceuticals, Gastroenterology, and Neuropsychiatry. The company commercializes both domestic and global brands — including exclusive India marketing rights for Alliance Pharmaceuticals' NIZRAL and NIZORAL — and has expanded into Cardio-Diabetic and Respiratory Care. Its product portfolio spans branded generics, specialty formulations, and nutritional supplements, several built on proprietary drug delivery platforms such as TNT (Tablet-in-Tablet), liposomal iron delivery, Dose-Balanced Formulation, and COLOMAT gastro-resistant controlled-release technology.

Alniche's go-to-market is sales-led and hospital-focused: a field force of 800+ Scientific Officers engages directly with specialist doctors, supported by an all-India distribution network of 5,000+ points. Marketing reach is reinforced through scientific conferences (ISNCON, ISGCON, IANCON, DERMACON), CME programs via the DSRC initiative, and digital channels including the My Healthytude YouTube platform and a CKD-focused Health App. The company collaborates with Delhi Pharmaceutical Sciences & Research University (DPSRU) since 2018 and, more recently, Jagannath University (2025) on co-development and talent pipelines.

In January 2021, Alniche extended into manufacturing through wholly-owned subsidiary Effikasia Lifesciences, marking a shift from pure marketing to integrated manufacturing-plus-marketing. The company holds ISO 9001:2015, ISO 13485:2016, and GDP certifications, is founder- and family-owned (Arora family), and operates without disclosed external institutional funding. Its stated long-term intent is geographic expansion beyond India into selected global markets.

Name

Alniche Life Sciences

Legal name

Alniche Life Sciences Pvt. Ltd.

Website

https://alniche.com

Company type

Private

Founded year

2007

Operating status

Operating

Headcount range

1–10 employees

Short description

Alniche Life Sciences is a New Delhi-based specialty pharmaceutical company marketing branded formulations across Renal Care, Gastroenterology, Neuropsychiatry, Skinceuticals, and Life Care to hospitals and specialist doctors across India through 800+ Scientific Officers and a 5,000-point distribution network.

Ownership category

akta.pro rank

Product category

Specialty Pharmaceuticals

NAICS

Drugs and Druggists' Sundries Merchant Wholesalers (42421), Biological Product (except Diagnostic) Manufacturing (325414)

SIC

Pharmaceutical Preparations (2834), Wholesale-Drugs, Proprietaries & Druggists' Sundries (5122)

akta.pro primary industry

Specialty Care Pharmaceuticals (HLAIAAAB)

akta.pro secondary industries

Primary Care & General Medicine Pharmaceuticals (HLAIAAAA), Specialty Pharmacy & Biologics Distribution (CRAOAHAD), Pain Management & Anesthesiology Pharmaceuticals (HLAIAAAN)

Keywords

• Specialty pharmaceuticals
• Renal care medicines
• Gastroenterology products
• Neuropsychiatry treatments
• Dermatology formulations

Headquarters

HQ city

New Delhi

HQ country

India

HQ region

Asia

Offices2 records

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Personnel, Supply Chain, Marketing or Sales, Operations, Technology or R&D

Revenue model

1. Pharmaceutical Product Sales: Revenue generated through sale of specialty pharmaceutical products across five therapy focus areas: Renal Care, Life Care, Skinceuticals, Gastroenterology, and Neuropsychiatry. The company commercializes both domestic and global brands, serving the hospital business as a major focus.

Go-to-market motion2 records

Distribution channels2 records

Marketing channels7 records

Core offering

Alniche Life Sciences is a specialty pharmaceutical marketing and distribution company that commercializes branded prescription and hospital-channel medicines across five niche therapy areas: Renal Care, Life Care (Critical Care), Skinceuticals (Dermatology), Gastroenterology, and Neuropsychiatry. The company develops proprietary novel drug delivery formulations, manufactures through subsidiary Effikasia Lifesciences, and distributes through 800+ Scientific Officers and 5000+ distribution points across India, serving as the preferred India-entry partner for global healthcare organizations.

Product overview

Alniche Life Sciences is a pharmaceutical company with a diversified product portfolio organized across five core therapy areas: Renal Care (including ALBUZEST-RENO, AUXIPRESS, Velacar, Zerofos, NEPHTIME), Life Care (including ALBUZEST, Wheybix Max, UBNICHE), Skinceuticals (including ANTHOCYN-TX, AQUAHOLD, Glutaup Soap), Gastroenterology (including ALBUZEST HEPA, Hepaniche, Esobiz, PEGEZE, Rifabiz, Udgrace), and Neuropsychiatry (including CEREKLAS, Gabaniche, Levialfa, BRIVATOP). The company also has a subsidiary Effikasia Lifesciences focused on manufacturing excellence. The portfolio includes branded generics, nutritional supplements, and specialized formulations across multiple therapeutic categories.

Differentiator

Problem solved

Functional benefit

Products and services

• Renal Care Product Portfolio Specialty pharmaceutical products for renal care including dialysis support (ALBUZEST-RENO, NEPHTIME, NEPHTIME-XT, RENOSTAR, RENOSPARK, RENOFILM, NUTRIFLORON), phosphate binders (Velacar with Sevelamer Carbonate, Zerofos and Zerofos-DS with Calcium Acetate), immunosuppressants for transplant (Biomus/Tacrolite with Tacrolimus, Biomyf/S with Mycophenolate), erythropoiesis stimulants (Darbitop with Darbepoetin Alfa), antihypertensives (AUXIPRESS, AUXIPRESS PLUS, Benibiz, Cinatab), antibiotics (AUXIFOS), nutritional support (Auximin 7%, Auxipro/XP/Forte, Bioshel, Folicab, Ferricab, KAFFCEL, MAGNICAL-D3, RenoCal, BUDEALFA), and metabolic acidosis management (Auxisoda/Auxisoda EC). Targeted at nephrologists and dialysis patients.
• Life Care / Critical Care Product Portfolio Critical care and general therapeutic products including nutritional supplements (ALBUZEST, Alferic-O, Alniche-Zinc, Alprogen, Altrack, Alvonic, Alzo-gold, Wheybix Max, AUXICAN), specialty antibiotics (ALFAPIME-TZ with Cefepime/Tazobactam, AUXIMEGA with Ceftriaxone combination, AUXICASP with Caspofungin, ZAVIALFA with Ceftazidime/Avibactam), Ubiquinol/Coenzyme Q10 supplement (UBNICHE), and specialty oncology formulation (Alphalan with Melphalan). Targeted at critical care specialists and hospitals.
• Skinceuticals / Dermatology Product Portfolio Dermatological products including antihistamines (ALECLOZ with Fexofenadine, Biladerm with Bilastine), skin brightening combinations (ANTHOCYN-TX and Anthocyn-TX Gold with Tranexamic acid and Glutathione), moisturizers (AQUAHOLD with Squalene/Aloe Vera/Vitamin E), specialty dermatology formulations (BIOMUS/BIOMUS FORTE with Tacrolimus), and skincare (Glutaup Soap with Glutathione, Vitsera Face Wash with Lumiskin/Vitamin C/Hyaluronic acid). Targeted at dermatologists.
• Gastroenterology Product Portfolio Gastrointestinal products including prokinetics (ACOCARE with Acotiamide), hepatic support formulations (ALBUZEST HEPA, ALCOFIX GOLD, Alcofix IV, ALDEKA, Alsame, Hepaniche, HEPANICHE XT, HEPANICHE-HMB, TOCOALFA), Vitamin D3 (COLEBRITE D3), bowel preparation (COLOWIPE NEO, Pegeze, PEGEZE PLUS), digestive enzymes (Creapase, CREASET GOLD), prokinetics and antiemetics (Entasafe), anti-ulcerants (Esobiz/DSR/L, Esobiz HP Kit), fiber supplements (Ezyfibre, DIGIFIBER with Dose-Balanced Formulation), antibiotics (Faroalfa CV, Faroalfa SR, Rifabiz), glutathione supplements (Glutaup, GLUTAUP-LP), pre-probiotics (Gutchamp), hypotension management (Hypodrin), IBS formulations (Mebehope, MEBEHOPE C), inflammatory bowel disease (Mesavin), multivitamins (MULTINICHE), gut health (Noleak, Prulitop), and cholestatic liver disease (Udgrace). Targeted at gastroenterologists.
• Neuropsychiatry Product Portfolio Neurological and psychiatric products including antiepileptics (BRIVATOP with Brivaracetam, Levialfa with Levetiracetam), neuroprotectants (CEREKLAS with Cerebroprotein Hydrolysate), cognitive enhancers (Citialfa-P with Citicoline/Piracetam), nerve health combinations (Combisafe, Gabaniche M, Gabaniche NT, Gabaklas NT), antidepressants (Escipix with Escitalopram), and muscle relaxants (Thioblis-A4/8, Topniche with Tolperisone). Targeted at neurologists and psychiatrists.
• Health App (Renal Care Digital Application) Digital health application launched on World Kidney Day to assist doctors in guiding Chronic Kidney Disease (CKD) patients through their treatment journey.

Named customers3 records

Segments5 records

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature4 records

Partnerships

Five partnerships are on record, tiered core and minor.

• Jagannath UniversitycoreStrategic or Co-development Partner · 1 January 2025MoU signed for Industry-Academia partnership to build a dynamic professional platform for university students and scholars, offering opportunities to intern with Alniche teams working on innovative real-world projects addressing therapy gaps in healthcare.
• Alliance Pharmaceuticals LimitedcoreGTM or Marketing Partner · 1 January 2020Exclusive partnership for marketing NIZRAL & NIZORAL brands in India. Alliance is a UK-based pharmaceutical company and Alniche serves as their exclusive marketing partner for these dermatology brands.
• Delhi Pharmaceutical Sciences & Research University (DPSRU)coreStrategic or Co-development Partner · 1 January 2018Academia-industry collaboration to research and develop innovative formulations in Nephrology & Critical care. Alniche funded a consortium to award young researchers (Jvalat and Vijayin awards) for bringing new concepts fulfilling Indian population needs. Also collaborated on Healthcare e-Compendium initiative.
• JW Lifesciences KoreaminorGTM or Marketing PartnerGlobal partner meet held at Alniche Head office where Sean Lee, Regional Sales Manager visited India for business discussions with Alniche Management.
• Effikasia LifesciencescoreOthersManufacturing entity established by Alniche forays into pharma manufacturing. Site linked as Effikasia.com for manufacturing excellence.

Scale indicators5 records

Recent moves9 records

Expansion highlights5 records

Broad incumbents

• Mankind Pharma: One of India's largest domestic pharma companies with deep specialty and primary care coverage across cardio-diabetic, GI, neuropsychiatry, and derma — directly competitive in many of Alniche's therapy areas, though at significantly greater scale.
• Alkem Laboratories: Indian specialty pharma with strong hospital-channel presence in anti-infectives, gastroenterology, and nephrology — comparable therapy mix and similar hospital/specialist GTM motion to Alniche.
• Intas Pharmaceuticals: Large Indian specialty pharma with leadership in nephrology/renal care and biosimilars — Alniche's primary renal care vertical most directly competes with Intas's franchise.
• Torrent Pharmaceuticals: Indian pharma with strong specialty franchises in cardio-diabetic, neuropsychiatry, and gastroenterology — overlapping therapy areas and similar specialist-physician engagement model.
• Glenmark Pharmaceuticals: Indian-headquartered specialty pharma with dermatology and gastroenterology franchises and global commercial footprint — comparable in specialty-care orientation though with broader international reach.
• Lupin: Major Indian pharma with specialty focus areas including gastroenterology, neuropsychiatry, and renal care — overlaps materially with Alniche's portfolio at much larger scale.

Direct peers

• Ajanta Pharma: India-focused specialty pharma with strong presence in cardiology, dermatology, and gastroenterology — closely comparable portfolio and India-domestic specialist marketing approach.
• JB Chemicals & Pharmaceuticals: India-focused pharma with strength in gastroenterology (prokinetics, PPIs) and nephrology — directly comparable specialty mix and similar specialty-physician GTM approach as Alniche.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights7 records

Customer concentration

• Xx.com/alnicheindia
• YouTubeyoutube.com/channel/UC3Bu1XkAnPTwrbRAPZKArHg
• Facebookfacebook.com/AlnicheIndia
• LinkedInlinkedin.com/company/alniche-life-sciences-pvt-ltd-
• Instagraminstagram.com/my_healthytude

Compliance3 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles6 records

Subsidiaries1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Alniche Life Sciences